Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Clinical trial NCT01852045 · COMPLETED
Trial details
- NCT number
- NCT01852045
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-02
- Primary completion
- 2018-10-11
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.